The Pharmaceutical Society of Australia (PSA) has partnered with Pharmaceutical Defence Limited (PDL) to increase collaboration about medicine safety and pharmacist practice support.
PSA National President Dr Fei Sim says the new partnership puts both organisations in a stronger position to make medicines safer for all Australians through excellence in pharmacist practice.
“We are stronger when we work together, and this will allow our organisations to collaborate on future medicine safety reports, and to progress medicine safety initiatives such as a nationally coordinated pharmacovigilance system,” she said.
PDL Board Chair Paul Naismith says that the agreement will unite PDL and PSA members, who share the common goal of improving medication safety in Australia.
“We’re excited to be working together with PSA to help tailor practice support across the profession in areas it will have the biggest impact on improving medicine safety,” he said.
The partnership will explore new medicine safety initiatives, including a future nationally coordinated pharmacovigilance system, medicine incident reporting and effective use of medicines.
Under the agreement, PSA will commence work on the sixth report in PSA’s Medicine Safety Report series.
A Practice Support Liaison Group will also be established to enhance support for pharmacists and the scope of practice across all areas of pharmacy practice.
“We look forward to supporting and working with PSA to further strengthen our great profession as it strives to deliver on Australia’s growing health needs,” Mr Naismith said.
